LUNDBECKFONDEN EMERGE
Lundbeckfonden Emerge seeks to identify and initiate commercial development of scientific opportunities which it considers from its analysis have high commercial potential. The main objective is to turn scientific discoveries and early stage opportunities into commercial ventures with a maturity that allows for full venture financing. Lundbeckfonden Emerge not only offers limited financing for selected cases but also offers seasoned advice or direct participation in new ventures, as part of i... ts unique model to optimize the outcome of the venture to the benefit of all stakeholders. Lundbeckfonden Emerge will seek to develop select projects together with founders and will take on an active role from mentoring to active project management, as is considered optimal for the outcome of the specific project. In this way, Lundbeckfonden Emerge is not a replication of traditional seed funds, but rather a unique way of using research funds to get to commercially viable projects.
LUNDBECKFONDEN EMERGE
Industry:
Finance
Founded:
2012-01-01
Status:
Active
Contact:
+45 39 12 80 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Nginx Organization Schema PHP Mobile Optimized FLoC Opt-Out Drupal
Similar Organizations
Comeback Capital
Comeback Capital is a pre-seed stage venture fund, that looks fund the buzzing startup ecosystem in the Midwest.
EuropeFX
EuropeFX offers a web-based trading platform for trading Forex, indices, CFDs, shares, and cryptocurrencies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-15 | NMD Pharma | Lundbeckfonden Emerge investment in Venture Round - NMD Pharma | 35 M EUR |
| 2021-05-04 | Cytoki Pharma | Lundbeckfonden Emerge investment in Series A - Cytoki Pharma | 45 M USD |
| 2021-01-13 | IO Biotech | Lundbeckfonden Emerge investment in Series B - IO Biotech | 127 M EUR |
| 2019-06-24 | AFYX Therapeutics | Lundbeckfonden Emerge investment in Debt Financing - AFYX Therapeutics | 13 M USD |
| 2018-03-23 | NMD Pharma | Lundbeckfonden Emerge investment in Series A - NMD Pharma | 38 M EUR |
| 2017-05-09 | AFYX Therapeutics | Lundbeckfonden Emerge investment in Series A - AFYX Therapeutics | 16.2 M EUR |
| 2016-07-01 | NMD Pharma | Lundbeckfonden Emerge investment in Venture Round - NMD Pharma | 2.7 M EUR |
More informations about "Lundbeckfonden Emerge"
Record year for the Lundbeck Foundation: Delivers best results ever
2021 was an exceptional year for the Lundbeck Foundation, delivering its best financial results ever. It was also a record year for the Foundation’s philanthropic activities with grants totalling …See details»
Lundbeckfonden Emerge - Crunchbase Investor Profile
Lundbeckfonden Emerge invests in early to late-stage therapeutics, pharmaceutical, and biotechnology companies, focusing on healthcare and science sectors, primarily in Denmark, …See details»
Lundbeck Foundation merges its portfolios of Danish and …
Oct 29, 2021 · Lundbeckfonden Emerge is an evergreen investor, founded by the Lundbeck Foundation in 2012 with the aim of scouting and investing in promising biotech opportunities …See details»
Lundbeckfonden Emerge - Issuu
Emerge is the Foundation’s early-stage, evergreen investment unit, building and financing biotech companies based on Danish research.See details»
The Lundbeck Foundation increases its commitment to IO Biotech
Jan 12, 2021 · The Lundbeck Foundation’s Danish biotech investments are grouped under Lundbeckfonden Emerge, which today has a portfolio of seven biotech companies, primarily …See details»
Letter from the Chairman and the CEO - Issuu
In October, we announced the merger of our two biotech direct investment teams, Lundbeckfonden Ventures and Lundbeckfonden Emerge, which takes effect in April 2022. Our …See details»
LUNDBECKFONDEN ANNUAL REPORT 2021 LUNDBECKFONDEN …
Direct investment teams, Lundbeckfonden Ventures and Lundbeckfonden Emerge, which takes eff ect in April 2022. Our biotech investments play a vital role in the Foundation’s strategy and …See details»
The Lundbeck Foundation
Back in 1954, Grete Lundbeck, the widow of Lundbeck’s founder Hans Lundbeck, established the Lundbeck Foundation by donating a large amount of her shares and willing the rest to the …See details»
Lundbeckfonden Emerge - Investments, Portfolio & Company Exits …
Nov 15, 2020 · Lundbeckfonden Emerge is a strategic initiative of the Lundbeckfonden established in the spring of 2012.See details»
BioCentury - Lundbeck VC unit narrows focus to Denmark, aims to …
Apr 7, 2022 · By concentrating its investments in Denmark in the coming years, Lundbeckfonden BioCapital intends to take advantage of the strengths in a growing local biotech environment …See details»
Lundbeck Foundation strategy translates early-stage research into …
Jun 25, 2021 · ‘Emerge is part of the Lundbeck Foundation and has an extremely exciting, dynamic portfolio of Danish biotech companies. Our strategy is to spot intriguing new research …See details»
Lundbeckfonden ruller dristig investeringsstrategi ud: Vil ... - Finans
Apr 4, 2022 · Lundbeckfonden Emerge, der altsÃ¥ nu bliver fusioneret med Lundbeckfonden Ventures til BioCapital, har investeret i syv danske selskaber. Det drejer sig om følgende: IO …See details»
Sustainability Report 2021 by Lundbeckfonden - Issuu
Mar 22, 2022 · SUSTAINABILITY AT THE LUNDBECK FOUNDATION With its 2030 strategy, Bringing Discoveries to Lives, the Lundbeck Foundation has articulated a clear commitment to …See details»
Lundbeck Foundation wants stronger biotech businesses in
Oct 21, 2021 · A managing partner at Lundbeckfonden Emerge would like to see more biotech businesses growing bigger and staying in Denmark, but this doesn't mean they can't also go …See details»
New Partner joins Lundbeckfonden Emerge
Dec 18, 2017 · Andreas Jurgeit is to join Lundbeckfonden Emerge, the early stage investment unit of the Lundbeck Foundation, as a partner on 1 January 2019. Andreas has been active in …See details»
Lundbeckfonden Emerge - Contacts, Employees, Board Members …
Lundbeckfonden Emerge is a strategic initiative of the Lundbeckfonden established in the spring of 2012.See details»
Lundbeck Foundation doubles its investment in Aarhus-based …
Oct 20, 2015 · Lundbeck Foundation recently decided to inject DKK 300 million into Lundbeckfond Emerge over four years, with the clear aim of boosting investment in promising biotech …See details»
Christian E. Elling - Managing Partner, Lundbeckfonden BioCapital ...
Christian E. Elling is the Managing Partner, Lundbeckfonden BioCapital at Lundbeckfonden Emerge. Additionally, Christian E. Elling has had 2 past jobs including CEO at Insusense …See details»
The Lundbeck Foundation
Towards 2030, we will double our regular grants for research in Denmark, build a clearer and more strategic focus on the brain, expand our portfolio of long-term ownership within the field …See details»
Series A - Cytoki Pharma - 2021-05-04 - Crunchbase
Webcapitalriesgo — Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND CapitalSee details»